Metabolomics identifies perturbations in human disorders of propionate metabolism.
about
Metabolomics: moving towards personalized medicineDirect detection of diverse metabolic changes in virally transformed and tax-expressing cells by mass spectrometryClinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic EraProposed guidelines for the diagnosis and management of methylmalonic and propionic acidemiaLC-MS-based metabolomicsMass Spectrometry-Based Metabolomic and Proteomic Strategies in Organic AcidemiasLiquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN databaseLaser desorption ionization mass spectrometry on silicon nanowell arrays.Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data.Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy.Medium-term variability of the human serum metabolome in the Atherosclerosis Risk in Communities (ARIC) studymetaXCMS: second-order analysis of untargeted metabolomics data.Semi-targeted analysis of metabolites using capillary-flow ion chromatography coupled to high-resolution mass spectrometry.MSClust: a tool for unsupervised mass spectra extraction of chromatography-mass spectrometry ion-wise aligned data.Plant-derived phenolics inhibit the accrual of structurally characterised protein and lipid oxidative modifications.Multiple organic anion transporters contribute to net renal excretion of uric acidHaystack, a web-based tool for metabolomics research.Metabolism of propionic acid to a novel acyl-coenzyme A thioester by mammalian cell lines and platelets.The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series)Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients.Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method.Serum fatty acid profiles and potential biomarkers of ankylosing spondylitis determined by gas chromatography-mass spectrometry and multivariate statistical analysis.The Harbin Cohort Study on Diet, Nutrition and Chronic Non-communicable Diseases: study design and baseline characteristics.Biomarker identification and pathway analysis by serum metabolomics of lung cancer.Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide.Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism.Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations.Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.Discovering oxysterols in plasma: a window on the metabolome.Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometryPlasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects.Challenges and opportunities of metabolomics.Clinical application of metabolomics in neonatology.Analytical approaches to the diagnosis and treatment of aging and aging-related disease: redox status and proteomics.Interrelations between 3-hydroxypropionate and propionate metabolism in rat liver: Relevance to disorders of propionyl-CoA metabolism.Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism.NMR-based multi parametric quality control of fruit juices: SGF profiling.N(8)-acetylspermidine as a potential plasma biomarker for Snyder-Robinson syndrome identified by clinical metabolomics.
P2860
Q21198748-0FC8813E-C7E9-4C9B-9E52-940D8C6FD018Q21562168-E85D21B4-11C0-4758-BA3C-4F114464E542Q26742050-3C801CE3-19ED-49FB-A3BB-5C6C6BB2563EQ26865440-94EED619-EAD8-4A40-ADD4-33688219CA3AQ27015012-68BEC591-3B27-422A-B62B-6C7E2404612CQ28077293-4A41F0F0-433E-4F90-96E8-0536272E796CQ28686521-D84B8FAC-A4C8-4CB6-81E7-51F7EF877801Q33447641-A4B7580F-06FD-46DA-8B88-2508A900C985Q33504770-3B5C1D21-D14E-434B-93CE-E15463AD1A14Q33675261-CBA5B746-AAB2-4C85-BA6B-30FA09FFFFA2Q33722880-4CA34FEE-A450-4EF1-A51A-281BD093B550Q33776895-0FF2B3F8-B50D-4BB8-BFD8-6AE8CDD24B47Q34049043-4241B080-F739-487A-95AC-931C5287E361Q34352188-744D8392-F61B-4E64-8EA4-C7FABFB3CE0CQ34405070-68B3AB3F-11DC-4226-B13B-51042E884EBDQ34470733-CEF1A074-9343-4B68-8BCE-45DFD7D588ADQ34606966-C21C09AB-410A-4A90-ADA3-2471E8E36A73Q34757371-B8DF2BDA-5B36-44C2-9213-BACEFEE35744Q34782469-33F0C269-02E8-478B-8814-B310696E0CBAQ35034053-BB24AEE4-28DA-4D4B-A4D9-F86D29F4D82BQ35211302-F15DA71E-71A2-4812-9F9F-42A111BCBF3FQ35253379-F1D16BF3-4303-4928-8B84-2325D4B74776Q35347520-C4C4B635-47AB-47E1-9037-34326145455BQ35557547-7647123C-21D0-4A44-898A-AADECEC539FBQ35775904-A9DDA65A-F781-41B4-B8F3-D23C2888075BQ36226348-80E59A1D-C056-47E4-93EC-449BEF71679CQ36245131-D86056D3-9115-48ED-99A0-941B848BC830Q36297407-4D484B04-8414-4067-8D08-5299531A2DE7Q36938182-5EA6E5A5-A0D3-40BD-AEA3-A6AE134B1B4AQ37009755-31E2A97B-5DD7-47C0-B78D-CDA9758164AFQ37271487-643275BD-F394-48F5-9769-54D022F052EBQ37370742-369FDE35-65E0-49F6-B0AB-4E82662CEE1CQ37835047-8D1DD5B5-3479-471C-A2B0-60F5956951B2Q37950296-25D31B9F-E934-4668-81C2-2D3F79FA8606Q37984553-05C891E6-9409-4BED-9222-76F32F9CCF78Q38396814-C936C575-1027-48DE-9D31-F259D56086B6Q38716517-7C9BA25C-2FA5-4FCB-8186-3DE9C98D8305Q39290476-FB17CC3D-85D2-432C-804D-29C6000B29EDQ40377198-37E0F382-EF9A-4900-95B5-3D823E89CCDAQ40736578-94C34E2D-36CB-4AA4-A9FB-D17FCECBD063
P2860
Metabolomics identifies perturbations in human disorders of propionate metabolism.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@en
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@nl
type
label
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@en
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@nl
prefLabel
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@en
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@nl
P2093
P1433
P1476
Metabolomics identifies perturbations in human disorders of propionate metabolism.
@en
P2093
Bruce A Barshop
Jon A Gangoiti
William R Wikoff
P304
P356
10.1373/CLINCHEM.2007.089011
P407
P50
P577
2007-10-19T00:00:00Z